Related Experiment Video
Updated: Jun 18, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis
Koji Okudela1, Takuya Yazawa, Jun Ishii
1Department of Pathology, Yokohama City University Graduate School of Medicine, Kanazawa-Ku, Yokohama, Japan.
Abstract:
FXYD3 is a FXYD-containing Na,K-ATPase ion channel regulator first identified as a protein overexpressed in murine breast tumors initiated by oncogenic ras or neu. However, our preliminary study revealed that FXYD3 expression was down-regulated in oncogenic KRAS-transduced airway epithelial cells. This contradiction led us to investigate the role of FXYD3 in carcinogenesis of the lung. FXYD3 mRNA and protein levels were lower in most of the lung cancer cell lines than in either the noncancerous lung tissue or airway epithelial cells. Protein levels were also lower in a considerable proportion of primary lung cancers than in nontumoral airway epithelia; FXYD3 expression levels decreased in parallel with the dedifferentiation process. Also, a somatic point mutation, g55c (D19H), was found in one cell line. Forced expression of the wild-type FXYD3, but not the mutant, restored the well-demarcated distribution of cortical actin in cancer cells that had lost FXYD3 expression, suggesting FXYD3 plays a role in the maintenance of cytoskeletal integrity. However, no association between FXYD3 expression and its promoter's methylation status was observed. Therefore, inactivation of FXYD3 through a gene mutation or unknown mechanism could be one cause of the atypical shapes of cancer cells and play a potential role in the progression of lung cancer.
Insights
FXYD3 (FXYD domain-containing ion-transport associated protein 3) is downregulated in lung cancer, potentially contributing to cancer cell shape changes and progression. Its inactivation may be linked to gene mutations.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- FXYD3 (FXYD domain-containing ion-transport associated protein 3) is a regulator of Na,K-ATPase.
- Initially identified as overexpressed in breast tumors, its role in lung cancer was unclear.
- Preliminary data showed FXYD3 downregulation in KRAS-mutated lung cells.
Purpose of the Study:
- Investigate the role of FXYD3 in lung carcinogenesis.
- Determine FXYD3 expression levels in lung cancer.
- Explore the functional impact of FXYD3 loss in lung cancer.
Main Methods:
- Quantitative analysis of FXYD3 mRNA and protein in lung cancer cell lines and primary tumors.
- Mutation analysis of the FXYD3 gene.
- Functional assays involving forced expression of wild-type and mutant FXYD3.
- Assessment of cytoskeletal organization (cortical actin distribution).
- Analysis of FXYD3 promoter methylation status.
Main Results:
- FXYD3 expression was significantly lower in most lung cancer cell lines and primary tumors compared to non-cancerous lung tissue.
- Decreased FXYD3 levels correlated with tumor dedifferentiation.
- A somatic mutation (g55c, D19H) was identified in one cell line.
- Restoration of wild-type FXYD3, but not mutant, normalized cortical actin distribution in FXYD3-deficient cancer cells.
- No association was found between FXYD3 expression and promoter methylation.
Conclusions:
- FXYD3 inactivation, potentially via gene mutation or other mechanisms, may contribute to altered cell morphology in lung cancer.
- FXYD3 plays a role in maintaining cytoskeletal integrity.
- FXYD3 inactivation could be a factor in lung cancer progression.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...